Skip to content

HSCSW

HeartSciences Inc.

NASDAQ · Healthcare · Medical - Devices · US

$0.05
+25.17%
Ask drillr

Year over year

Reported trailing growth

Revenue
-27.7%
EBITDA
+99.5%
EBIT
-16.3%
EPS
+61.4%
Free cash flow
Operating cash flow

Forward estimates

Based on analyst estimates

Revenue
EBITDA
+12.2%
EPS
+21.6%

Three-year CAGR

Revenue
-5.7%
EBITDA
-2.3%
EBIT
-0.7%
Net income
-4.3%
EPS
+62.7%
Free cash flow
-0.4%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026